Prestigious research universities that develop their own patents appear no more likely to enjoy sovereign immunity at the Patent and Trademark Office than Indian tribes that buy theirs.

The U.S. Court of Appeals for the Federal Circuit signaled strongly Monday that its same rationale for turning away Native American sovereign immunity last summer in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals will apply equally to state sovereign immunity.